共 50 条
- [1] Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomyANNALS OF ONCOLOGY, 2022, 33 (07) : S1106 - S1106Min, L. Z.Liu, N.Zhou, Y.Niu, Z.
- [2] Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy: Data update.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16044 - E16044Liu, ZiminLiu, NingZhou, YanbingNiu, ZhaojianJiang, HaitaoZhu, YingqianWang, HuiyunLi, XiaoxiaoSong, ShanaiLiu, XiaodongLi, ZequnZhao, Shufen
- [3] Efficacy and safety of camrelizumab combined with FOLFOX as neoadjuvant therapy for patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Zhao, YuzhouHan, GuangsenZhuang, JingLi, ZhimengWang, GangchengLi, BaodongWang, JinbangGu, YanhuiMa, PengfeiZhang, JunliCao, YanghuiLiu, ChenyuLi, SenZhang, Xijie
- [4] Camrelizumab combined with FOLFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Liu, YingHan, GuangsenLi, HongleZhao, YuzhouZhuang, JingWang, GangchengLi, BaodongWang, JinbangLi, ZhimengXia, QingxinMa, JieZhang, ChengjuanYu, JuanLi, KeXu, ShuningQiao, LeiKuang, GaizhenLi, Danyang
- [5] Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Liu, YingHan, GuangsenLi, HongleZhao, YuzhouLi, ZhiZhuang, JingWang, GangchengLi, BaodongWang, JinbangLi, ZhimengXia, QingxinZhang, ChengjuanYu, JuanLi, KeXu, ShuningQiao, LeiKuang, GaizhenLi, Danyang
- [6] FLOT Neoadjuvant Chemotherapy Followed by Laparoscopic D2 Gastrectomy in the Treatment of Locally Resectable Advanced Gastric CancerCANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020Zhang, ShunYan, DongyiSun, QiDu, TaoCao, DongliangYang, YaoYuan, BiaoLi, HaiqiangJiang, XiaohuaSong, Chun
- [7] Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II studyANNALS OF ONCOLOGY, 2023, 34 : S66 - S67Zhou, H.Long, B.Yu, Z.Zhu, J.Yang, H.Zhang, W.Guan, X.Zhang, G.Li, L.Luo, C.Cao, H.Zhang, S.Chen, S.He, Q.Gan, S.Zhou, L.Jiang, X.Shi, W.Huang, Z.Mao, J.Dong, C.Jiao, Z.
- [8] Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Li, HongliDeng, JingyuGe, ShaohuaZang, FenglinZhang, LeRen, PengWang, BaoguiCao, FuliangDeng, TingLiu, RuiNing, TaoYang, YuchongBai, MingWang, XiaJi, ZhiDuan, JingjingLiu, YongZhou, DejunLiang, HanBa, Yi
- [9] Efficacy and safety of cadonilimab combined with FLOT regimen as a neoadjuvant therapy for locally advanced gastric/gastroesophageal junction adenocarcinoma: A prospective, multicenter, open-label, single-arm phase II studyANNALS OF ONCOLOGY, 2023, 34 : S70 - S71Long, B.Zhou, H.Wei, D.Yang, T.Chai, N.Yu, Z.Yang, H.Guan, X.Zhang, W.Chen, S.Zhou, L.Jiang, X.Shi, W.Huang, Z.Zhu, J.Luo, C.Mao, J.Dong, C.Jiang, Z.Zhao, X.Zhao, D.Jiao, Z.
- [10] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable locally advanced esophageal squamous cell carcinomaANNALS OF ONCOLOGY, 2024, 35 : S168 - S168Yoshinami, Y.Yamamoto, S.Shiraishi, K.Itoyama, M.Imazeki, H.Yokoyama, K.Honma, Y.Kurita, D.Ishiyama, K.Oguma, J.Daiko, H.Kato, K.